Tuesday , 18 May 2021

Resealed Erythrocytes- A Review

Santhoshi Hiranmai, Venugopalaiah P*
Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolur, Nellore, Andhra Pradesh, India-524346

A B S T R A C T
Among the various carriers used for targeting drugs to various body tissues, the cellular carriers meet several criteria desirable in clinical applications, among the most important being biocompatibility of carrier and its degradation products. Leucocytes, platelets, erythrocytes, nano erythrocytes, hepatocytes, and fibroblasts etc. have been proposed as cellular carrier systems. Among these, the erythrocytes have been the most investigated and have found to possess greater potential in drug delivery. Biopharmaceuticals, therapeutically significant peptides and proteins, nucleic acid-based biological, antigens, anticancer drug and vaccines, are among the recently focused pharmaceuticals for being delivered using carrier erythrocytes. Erythrocytes, also known as red blood cells, and have been extensively studied for their potential carrier capabilities for the delivery of drugs. The biocompatibility, nonpathogenicity, non-immunogenicity and biodegradability make them unique and useful carriers. Carrier erythrocytes are prepared by collecting blood sample from the organism of interest and separating erythrocytes from plasma. By using various methods the cells are broken and the drug is entrapped into the erythrocytes, finally they are resealed and the resultant carriers are then called “resealed erythrocytes”. So many drugs like aspirin, steroid, cancer drug which having many side effects are reduce by resealed erythrocyte. Current review highlights isolation, drug loading methods, Evaluation methods and applications of resealed erythrocytes for drug delivery
Keywords: Red blood cells, Heamoglobin, Resealed erythrocytes, Heamolysis

Scroll To Top